Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Causality of rhabdomyolysis and combined tetanus, diphtheria and acellular pertussis (Tdap) vaccine administration.

Kulkarni H, Lenzo N, McLean-Tooke A.

J Clin Pharmacol. 2013 Oct;53(10):1099-102. doi: 10.1002/jcph.145. Epub 2013 Aug 1. No abstract available.

PMID:
23913623
2.

Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.

Weston WM, Friedland LR, Wu X, Howe B.

Vaccine. 2012 Feb 21;30(9):1721-8. doi: 10.1016/j.vaccine.2011.12.055. Epub 2011 Dec 31.

PMID:
22212127
4.
5.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases..

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
6.

Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.

Sato H, Sato Y.

Clin Infect Dis. 1999 Jun;28 Suppl 2:S124-30.

PMID:
10447030
8.
9.

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial.

Beytout J, Launay O, Guiso N, Fiquet A, Baudin M, Richard P, Baptiste C, Soubeyrand B.

Hum Vaccin. 2009 May;5(5):315-21. Epub 2009 May 1.

PMID:
19011374
10.

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults.

Halperin SA, Smith B, Russell M, Scheifele D, Mills E, Hasselback P, Pim C, Meekison W, Parker R, Lavigne P, Barreto L.

Pediatr Infect Dis J. 2000 Apr;19(4):276-83.

PMID:
10783014
11.

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2012 Jun 29;61(25):468-70. Erratum in: MMWR Morb Mortal Wkly Rep. 2012 Jul 13;61(27):515.

12.

Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine.

Weston W, Messier M, Friedland LR, Wu X, Howe B.

Vaccine. 2011 Nov 3;29(47):8483-6. doi: 10.1016/j.vaccine.2011.09.063. Epub 2011 Sep 25.

PMID:
21945698
13.
14.

Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.

Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.

Vaccine. 2005 May 25;23(28):3657-67.

PMID:
15882526
15.

Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.

Lee SY, Hwang HS, Kim JH, Kim HH, Lee HS, Chung EH, Park SE, Ma SH, Chang JK, Guitton F, Ortiz E, Kang JH.

Vaccine. 2011 Feb 11;29(8):1551-7. doi: 10.1016/j.vaccine.2010.12.094. Epub 2011 Jan 6.

PMID:
21215828
16.

Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.

Bernstein HH, Rothstein EP, Reisinger KS, Blatter MM, Arbeter AM, Fontana ME, Jacobs JM, Long SS, Rathfon H, Crayne O, et al.

Pediatrics. 1994 Apr;93(4):656-9.

PMID:
8134224
17.

Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.

Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D.

Pediatrics. 2006 Sep;118(3):e602-9.

PMID:
16950952
18.

Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults.

Hoel T, Wolter JM, Schuerman LM.

Eur J Emerg Med. 2006 Apr;13(2):67-71.

PMID:
16525231
19.

Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.

Pichichero ME, Blatter MM, Kennedy WA, Hedrick J, Descamps D, Friedland LR.

Pediatrics. 2006 Apr;117(4):1084-93.

PMID:
16585302
20.

Tdap vaccine: current indications for adolescent and adult patients in the United States.

Kirchner JT.

J Am Osteopath Assoc. 2011 Oct;111(10 Suppl 6):S7-9.

PMID:
22086895

Supplemental Content

Support Center